The CSF CHI3L1 level in ALS patients exhibited a significant increase compared to the AMDS (ALS-C pooled SMD, 1.92; 95% CI, 0.41 – 3.42; P < 0.001) (Fig. 7). Here, CHI3L1 is linked to amyotrophic lateral sclerosis.